Evidence map›Paper›PMID 34184975›Full record

ArticleHuman vaccines & immunotherapeutics2021

CAR-based cell therapy: evaluation with bibliometrics and patent analysis.

Yajun Yuan, Qihan Fu, Yaqun Zhang, Danhai Xu, Yeqing Wu, Qiufei Qiu, Wuyuan Zhou

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yajun YuanZhejiang Academy of Science and Technology Information, Hangzhou, China.
Qihan FuSchool of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Yaqun ZhangLibrary of Zhejiang University, Hangzhou, China.
Danhai XuZhejiang Academy of Science and Technology Information, Hangzhou, China.
Yeqing WuZhejiang Academy of Science and Technology Information, Hangzhou, China.
Qiufei QiuZhejiang Academy of Science and Technology Information, Hangzhou, China.
Wuyuan ZhouZhejiang Academy of Science and Technology Information, Hangzhou, China.ORCID 0000-0001-5506-3373

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chimeric antigen receptors-based cell therapies have shown impressive preclinical and clinical success and revolutionized biomedicine. However, the link between science and invention, the impact of international cooperation, and the influence and prestige of CARs research have not been explored. This study analyzed the landscape of peer-reviewed articles and patents related to CARs. A total of 5,681 publications were analyzed using bibliometrics and machine learning-based text mining to assess publication metrics, subject areas, and research hotspots. 5,010 Inpadoc families were also analyzed for patent filing trends, priority countries, and applicant and inventor rankings. The results show that CARs research has the following distinctive features: high research prestige among research community; strong global geographical bias in both academic output and patenting patterns; strong links between science and invention, but significant differences among countries; and an inverse relationship between country size and international collaboration rates.

Indexed as

BibliometricsImmunotherapy, AdoptiveCell- and Tissue-Based TherapyData MiningHumansbibliometricsCAR T cell therapyChimeric antigen receptors (CARs)patent landscaperesearch hotspots

Identifiers

PMID34184975
PMCPMC8827635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.